ERNA vs MKTX · P/E 0.0, rev $582.0K vs P/E 13, rev $817.1M
Eterna Therapeutics Inc (ERNA) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the ERNA and MKTX stock pages for the full models.
Not investment advice.